Loading...
Focus on α4β2* and α6β2* nAChRs for Parkinson’s Disease Therapeutics
L-dopa is one of the best treatments for the motor symptoms of Parkinson’s disease. However, its use is limited by the fact that it provides only symptomatic relief and chronic therapy leads to dyskinesias. There is therefore a continual search for novel therapeutic approaches. Nicotine, a drug that...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3076673/ https://ncbi.nlm.nih.gov/pubmed/21499569 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|